乳酸/白蛋白比值对危重脓毒症患者28天死亡率的预测价值
本研究为韩国休克学会10家教学医院急诊科参与的前瞻性收集多中心登记库的回顾性观察研究,纳入946例≥19岁、疑似或确诊感染且存在难治性低血压或低灌注证据的危重脓毒症患者。乳酸和白蛋白于急诊到达后立即测量。总体28天死亡率为22.5%。乳酸/白蛋白比值预测28天死亡率的AUROC为0.69(95%CI 0.64-0.73,P<0.01),高于乳酸的0.65(95%CI 0.61-0.70,P<0.01),最佳切点为1.32。无论乳酸水平正常、中间或升高,以及存在肝或肾功能障碍时,乳酸/白蛋白比值的AUROC均优于乳酸。
要点
- 在946例危重脓毒症患者中,乳酸/白蛋白比值预测28天死亡的AUROC为0.69(95%CI 0.64-0.73,P<0.01),优于乳酸0.65(95%CI 0.61-0.70,P<0.01)。
- 乳酸/白蛋白比值预测28天死亡率的最佳切点为1.32。
- 乳酸正常(<2.0 mmol/L)亚组中,乳酸/白蛋白比值AUROC为0.68 vs 乳酸0.55;中间乳酸(≥2.0且<4.0 mmol/L)亚组为0.65 vs 0.50;高乳酸(≥4.0 mmol/L)亚组为0.66 vs 0.62。
- 在乳酸清除减少的亚组中,乳酸/白蛋白比值AUROC亦显著高于乳酸:肝功能障碍亚组0.70 vs 0.66,肾功能障碍亚组0.71 vs 0.67。
- 即使在乳酸正常或中间水平的患者中,乳酸/白蛋白比值切点和低白蛋白血症对28天死亡率显示出进一步区分价值。
适用人群与场景
- 年龄19岁及以上、疑似或确诊感染且存在难治性低血压或低灌注证据的危重脓毒症患者,来自韩国休克学会10家教学医院急诊科的前瞻性收集多中心登记库。
诊断标准与关键阈值
- 乳酸/白蛋白比值预测28天死亡率的最佳切点为1.32。
- 乳酸水平分层:正常<2.0 mmol/L;中间≥2.0且<4.0 mmol/L;高≥4.0 mmol/L。
研究设计与关键结果
- 研究类型为来自前瞻性收集多中心登记库的回顾性观察研究,纳入946例患者,总体28天死亡率为22.5%。
- 乳酸/白蛋白比值预测28天死亡率的AUROC为0.69(95%CI 0.64-0.73,P<0.01),高于乳酸的0.65(95%CI 0.61-0.70,P<0.01)。
- 乳酸/白蛋白比值最佳切点为1.32。
- 按乳酸水平分层,乳酸/白蛋白比值AUROC均优于乳酸:正常乳酸组0.68 vs 0.55;中间乳酸组0.65 vs 0.50;高乳酸组0.66 vs 0.62。
- 在乳酸清除减少亚组中,乳酸/白蛋白比值AUROC亦显著高于乳酸:肝功能障碍组0.70 vs 0.66;肾功能障碍组0.71 vs 0.67。
- 即使在乳酸正常或中间水平的患者中,乳酸/白蛋白比值切点和低白蛋白血症对28天死亡率显示出进一步区分价值。
证据类型、等级与局限
- 证据类型:来自前瞻性收集多中心登记库的回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,乳酸/白蛋白比值可作为有用的预后因素,无论初始乳酸水平及是否存在肝或肾功能障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: The aim of this study was to evaluate the clinical utility of the lactate/albumin (L/A) ratio as a predictive factor of 28-day mortality in critically ill sepsis patients.
METHODS: This is a retrospective observational study from a prospectively collected multicenter registry of 10 emergency departments (EDs) in teaching hospitals that participated in the Korean Shock Society. It enrolled patients who were 19 years of age or older who had a suspected or confirmed infection and evidence of refractory hypotension or hypoperfusion. The prognostic performance of the L/A ratio and lactate level for predicting 28-day mortality was assessed. Lactate and albumin levels were measured immediately after ED arrival.
RESULTS: A total of 946 patients were included, with 22.5% overall 28-day mortality. The area under the receiver operating characteristic curve (AUROC) value of the L/A ratio (0.69, 95% confidence interval [CI] 0.64-0.73, P < 0.01) was higher than that of lactate (0.65, 95% CI 0.61-0.70, P < 0.01) for predicting 28-day mortality. The optimal cutoff of the L/A ratio was 1.32. The AUROC value of the L/A ratio was better than that of lactate regardless of lactate level (normal [<2.0 mmol/L]: 0.68 vs. 0.55; intermediate [≥2.0, < 4.0 mmol/L]: 0.65 vs. 0.50; high [≥4.0 mmol/L]: 0.66 vs. 0.62). In the subgroup with decreased lactate elimination, the AUROC value of the L/A ratio was also significantly higher than that of lactate (hepatic dysfunction: 0.70 vs. 0.66; renal dysfunction: 0.71 vs. 0.67). The L/A ratio cut-off and hypoalbminemia showed further discriminative value for 28-day mortality even in patients with normal or intermediate lactate levels.
CONCLUSIONS: The prognostic performance of the L/A ratio was superior to that of a single lactate measurement for predicting 28-day mortality of critically ill sepsis patients. L/A ratio can be a useful prognostic factor regardless of initial lactate level and the presence of hepatic or renal dysfunction.
参考来源
- Shin J, Hwang SY, Jo IJ, et al. Prognostic Value of The Lactate/Albumin Ratio for Predicting 28-Day Mortality in Critically ILL Sepsis Patients. Shock. 2018. PMID: 29461463. doi:10.1097/SHK.0000000000001128
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。